Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The Oncologist|August 1, 2021
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single-Dose Administration Under Fasting Conditions in Prostate CancerLisa M Cordes, Keith T Schmidt, Cody J Peer, et al.
Journal of the Endocrine Society|December 22, 2017
Somatic <i>VHL</i> Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case ReportJasmine Shell, Dhaval Patel, Astin Powers, et al.
The Oncologist|December 30, 2025
A phase 2 study of GI-6207 in patients with recurrent medullary thyroid cancerJaydira Del Rivero, Renee N Donahue, Jennifer L Marte, et al.
Clinical Genitourinary Cancer|June 12, 2021
Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair MutationsVincent Chau, Ravi A Madan, Marijo Bilusic, et al.
Frontiers in Oncology|March 20, 2023
First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case reportMohammad O Atiq, Danielle M Pastor, Fatima Karzai, et al.
The Oncologist|December 27, 2025
Pembrolizumab in Recurrent or Metastatic Medullary Thyroid CancerJaydira Del Rivero, Renee N Donahue, Jennifer L Marte, et al.
Scientific Reports|April 30, 2026
HyperHealth: a pilot study on AI-driven COVID-19 detection using hyperspectral fingertip imagesEmanuela Marasco, Shruti Wagle, Mason Rule, et al.
Journal for Immunotherapy of Cancer|September 7, 2019
Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumorsMarijo Bilusic, Christopher R Heery, Julie M Collins, et al.
The Prostate|November 2, 2018
Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Robert B Den, Maria I Carlo, et al.
Clinical Genitourinary Cancer|April 25, 2020
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide TreatmentRavi A Madan, Keith T Schmidt, Fatima Karzai, et al.
Pageof 7